(TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical-stage pharmaceutical company dedicated to the research ...
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...
Cash balance of $116 million as of June 30, 2026 expected to fund operations through the end of 2028, supporting anticipated ...
Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization ...
About Nuvectis Pharma, Inc. Nuvectis Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development of ...
Oxford Brain Diagnostics (OBD), a pioneer in quantitative brain biology, today announced new research demonstrating that its ...
WELTRUZA ™ (olanzapine) for extended-release injectable suspension is the first and only once-monthly subcutaneous ...
Denifanstat showed continued improvement and sustained efficacy across all efficacy endpoints through 52 weeks, including 57% ...
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing ...
Publication of the peer-reviewed papers comes as iOnctura awaits readouts from its two fully-enrolled, randomized Phase II ...
Lakshmi Srinivasan, PhD, former Executive Director and Head of Oncology Translational Medicine at Moderna, and Brandon Coder, ...
(“TRexBio”) (Nasdaq: TRXB), a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results